Emergent BioSolutions Closes two Maryland Facilities, Cuts 300 Jobs. Now What?
CBRE Report Highlights Growth in Maryland During Q1 2024
Published on :Image Credit: CBRE U.S. Real Estate Market Outlook 2024 CBRE Report Highlights Growth in Maryland During Q1 2024 The Maryland life sciences market continues to perform reliably, with 138,000 square [….]
BioLabs Investor Day Attracts 65 Startups and 30 Investors to Philadelphia
Published on :VerImmune pitches at 2nd Annual BioLabs Philadelphia Investor Day
BioBuzz Networks and the International Society of Pharmaceutical Engineering – Chesapeake Bay Area Chapter Announce Exciting Partnership
Published on :BioBuzz Networks and the International Society of Pharmaceutical Engineering – Chesapeake Bay Area Chapter Announce Exciting Partnership Alliance will further strengthen Maryland’s Life Sciences Community March 28, 2024, Baltimore, MD. [….]
What’s the Buzz?! Building Better Leaders and Teams
Published on :Roshni Rao, Executive Director of Doctoral and Postdoctoral Career Design and the Director of Phurutures for The Johns Hopkins University and Chris Frew, CEO, BioBuzz Networks, sat down to buzz about the outlook for PhD’s in 2024
How Life Science Companies are Extending their Budgets in 2024
Published on :How Life Science Companies are Extending their Budgets in 2024
5 Questions With Akshay Nadkarni, Director, CMC Program Management, Kymanox
Published on :5 Questions With Akshay Nadkarni, Director, CMC Program Management, Kymanox February 8, 2024 Akshay Nadkarni is a Director, CMC Program Management at Kymanox, with 12 years of experience in implementing [….]
Buzzin’ Brood: Student Spotlight, Deeksha Surisetty, M.S. Biotechnology
Published on :Buzzin’ Brood: Student Spotlight, Deeksha Surisetty, M.S. Biotechnology February 6, 2024 Name: Deeksha Surisetty Hometown: McKinney, Texas Academic/Training Institution + Degree/Certification: B.S. Neuroscience- University of Texas at Dallas, M.S. Biotechnology- [….]
AstraZeneca Investing $300 Million into New Cutting-Edge Cell Therapy Facility in Maryland
Published on :AstraZeneca Investing $300 Million into New Cutting-Edge Cell Therapy Facility in Maryland February 6, 2024 In a recent press release, Governor Wes Moore announced a groundbreaking initiative that positions Maryland [….]
Novo Holdings $16.5 B. Acquisition of Catalent Secures Production Demand for Weight-loss Drug Wegovy
Published on :Novo Holdings announced the acquisition of Catalent, Inc. (NYSE: CTLT).